Related Experiment Video
Updated: Jun 4, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Non-responders to cardiac resynchronization therapy: the magnitude of the problem and the issues
Angelo Auricchio1, Frits W Prinzen
1Division of Cardiology, Fondazione Cardiocentro Ticino, Via Tesserete 48, Lugano, Switzerland. angelo.auricchio@cardiocentro.org
Insights
Many patients do not benefit from cardiac resynchronization therapy (CRT). Identifying non-responders using risk stratification and clinical scores may improve patient selection for CRT.
Area of Science:
- Cardiology
- Medical Technology
Background:
- A significant proportion of patients undergoing cardiac resynchronization therapy (CRT) do not respond to the treatment.
- The increasing prevalence of heart failure necessitates improved patient selection for CRT to optimize resource allocation.
Purpose of the Study:
- To discuss the definition and parameters of response to CRT.
- To explore methods for predicting non-response to CRT.
- To evaluate current strategies for patient selection and propose improvements.
Main Methods:
- Review of existing literature on CRT response and non-response.
- Analysis of parameters influencing CRT outcomes, including imaging and clinical data.
- Discussion of the limitations of current patient selection methods.
Main Results:
- Current methods for predicting CRT response have limitations.
- Patient selection for CRT has not been optimized, leading to suboptimal resource utilization.
- Mechanical dyssynchrony measures often face technical and interpretational challenges.
Conclusions:
- Risk stratification incorporating left ventricular volumes, etiology, and QRS characteristics may better define non-responders than universal cut-off values.
- Simple clinical scores could refine outcome prediction and improve daily practice measurement of CRT response.
- Further research is needed to overcome technical limitations of imaging modalities for better patient selection.
Abstract:
A variable proportion of cardiac resynchronization therapy (CRT) patients do not benefit from treatment (termed `non-responders'). The problem of non-response to CRT might become increasingly important, because it is anticipated that larger groups of heart failure patients are indicated to the therapy. This article will discuss the definition of response to CRT, the parameters related to response to CRT, and finally whether response to CRT might be predicted. The effort to improve patient selection in order to maximize human and financial resource utilization has fallen short so far. It is, however, conceivable that rather than the identification of a `universally' applicable cut-off value, risk strata-in which inclusion of method for determination of left ventricular volumes, etiology, QRS duration and morphology, etc-might better serve the goal of defining non-responders. Potentially simple clinical scores might help in refining outcome and by doing so, allow to more precisely measure response to CRT in daily practice in the individual patient at the time of CRT implantation. Although sophisticated cardiac imaging modalities have been intensively utilized for improving patient outcome, it seems that many mechanical dyssynchrony measures suffer from technical limitations and from difficult interpretation of the complex signals, which lack reproducibility outside highly specialized laboratories.
More Related Videos
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
08:33A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
Published on: January 5, 2024
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management